These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2121485)

  • 1. Oxidative modification of LDL: comparison between cell-mediated and copper-mediated modification.
    Parthasarathy S; Fong LG; Quinn MT; Steinberg D
    Eur Heart J; 1990 Aug; 11 Suppl E():83-7. PubMed ID: 2121485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification.
    Sparrow CP; Parthasarathy S; Steinberg D
    J Lipid Res; 1988 Jun; 29(6):745-53. PubMed ID: 3139813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular oxidative modification of low density lipoprotein does not require lipoxygenases.
    Sparrow CP; Olszewski J
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):128-31. PubMed ID: 1729678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.
    Parthasarathy S; Wieland E; Steinberg D
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1046-50. PubMed ID: 2536929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of 15-lipoxygenase by low density lipoprotein in vascular endothelial cells. Relationship to the oxidative modification of low density lipoprotein.
    Derian CK; Lewis DF
    Prostaglandins Leukot Essent Fatty Acids; 1992 Jan; 45(1):49-57. PubMed ID: 1546066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex.
    Cathcart MK; McNally AK; Chisolm GM
    J Lipid Res; 1991 Jan; 32(1):63-70. PubMed ID: 1901344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis.
    Rosenfeld ME; Palinski W; Ylä-Herttuala S; Carew TE
    Toxicol Pathol; 1990; 18(4 Pt 1):560-71. PubMed ID: 2091235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages.
    Rankin SM; Parthasarathy S; Steinberg D
    J Lipid Res; 1991 Mar; 32(3):449-56. PubMed ID: 1906087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
    Ylä-Herttuala S; Palinski W; Rosenfeld ME; Parthasarathy S; Carew TE; Butler S; Witztum JL; Steinberg D
    J Clin Invest; 1989 Oct; 84(4):1086-95. PubMed ID: 2794046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endothelial cells and their products in the modification of low-density lipoproteins.
    van Hinsbergh VW; Scheffer M; Havekes L; Kempen HJ
    Biochim Biophys Acta; 1986 Aug; 878(1):49-64. PubMed ID: 3730414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation.
    Lesnik P; Dentan C; Vonica A; Moreau M; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1121-30. PubMed ID: 7627705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway.
    McNally AK; Chisolm GM; Morel DW; Cathcart MK
    J Immunol; 1990 Jul; 145(1):254-9. PubMed ID: 2162888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques.
    Folcik VA; Nivar-Aristy RA; Krajewski LP; Cathcart MK
    J Clin Invest; 1995 Jul; 96(1):504-10. PubMed ID: 7615823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages.
    de Whalley CV; Rankin SM; Hoult JR; Jessup W; Leake DS
    Biochem Pharmacol; 1990 Jun; 39(11):1743-50. PubMed ID: 2344371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDL-platelet interaction under oxidative stress induces macrophage foam cell formation.
    Aviram M
    Thromb Haemost; 1995 Jul; 74(1):560-4. PubMed ID: 8578524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of human low-density lipoprotein by soybean 15-lipoxygenase in combination with copper (II) or met-myoglobin.
    O'Leary VJ; Graham A; Stone D; Darley-Usmar VM
    Free Radic Biol Med; 1996; 20(4):525-32. PubMed ID: 8904293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.
    Quinn MT; Parthasarathy S; Fong LG; Steinberg D
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2995-8. PubMed ID: 3472245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative modification of low density lipoproteins by human polymorphonuclear leukocytes.
    Wieland E; Brandes A; Armstrong VW; Oellerich M
    Eur J Clin Chem Clin Biochem; 1993 Nov; 31(11):725-31. PubMed ID: 8305616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL.
    Sigari F; Lee C; Witztum JL; Reaven PD
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3639-45. PubMed ID: 9437216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation.
    Parthasarathy S; Quinn MT; Schwenke DC; Carew TE; Steinberg D
    Arteriosclerosis; 1989; 9(3):398-404. PubMed ID: 2719599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.